Warning For Novartis
Novartis AG (NVS) was down sharply at the middle of the session after an FDA warning. The company’s drug, GILENYA, was warned to cause severe worsening of M.S. symptoms once a patient discontinues use of the treatment. This caused the stock to drop sharply from just above $89 to nearly $86. The stock closed the […]
Read Article